ClinicalTrials.Veeva

Menu

Rebound Pain After Peripheral Nerve Blocks in Total Knee Arthroplasty

K

Konya City Hospital

Status

Not yet enrolling

Conditions

Postoperative Pain
Peripheral Nerve Block
Pain Management
Rebound Pain
Total Knee Arthroplasty

Study type

Observational

Funder types

Other

Identifiers

NCT06966011
2.02.2025-35892

Details and patient eligibility

About

This prospective observational study aims to determine the incidence and clinical impact of rebound pain after peripheral nerve blocks in patients undergoing total knee arthroplasty. Rebound pain is defined as a sudden, severe pain (NRS ≥7) emerging after block resolution. Primary outcome is the incidence of rebound pain; secondary outcomes include pain severity, rescue analgesia use, nausea, vomiting, sleep quality, and patient satisfaction.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 70 years
  • ASA physical status I to III
  • Scheduled for elective unilateral total knee arthroplasty under spinal anesthesia
  • Peripheral nerve block (PNB) planned as part of multimodal analgesia
  • Ability to understand and provide written informed consent
  • Willingness and ability to complete the postoperative pain diary

Exclusion criteria

  • Known allergy or hypersensitivity to local anesthetics
  • Contraindication to regional anesthesia
  • ASA physical status IV or higher
  • Neurological or psychiatric disorders interfering with study participation or pain reporting
  • Use of anticoagulants or presence of coagulopathy
  • Use of medications that may alter pain perception or rebound pain response
  • Local infection at the block site
  • Emergency surgeries
  • Inability or unwillingness to complete the postoperative pain diary or follow-up

Trial contacts and locations

1

Loading...

Central trial contact

Mahmut Tutar, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems